In the past three decades, the efficacy of IGF-1 had been reported in animal models of neurodegenerative disease including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and various peripheral neuropathies30. This evidence concerns the gene IGF1 and neurodegenerative disease.